10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

(Amendment No.1)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                 

BLUE SAFARI GROUP ACQUISITION CORP.

(Exact Name of Registrant as Specified in Charter)

British Virgin Islands	001-40473	n/a
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

Cheung Kong Center,

58th Floor, Unit 5801

2 Queens Road Central

Central

Hong Kong

(Address of Principal Executive Offices) (Zip Code)

+8529258 9728

(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, with no par value, and one right to receive one-tenth of one Class A ordinary share	BSGAU	The Nasdaq Stock Market LLC
Class A ordinary shares included as part of the units	BSGA	The Nasdaq Stock Market LLC
Rights included as part of the units	BSGAR	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	⌧	Smaller reporting company	⌧
Emerging growth company	⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒  No ☐

As of December 10, 2021, 6,100,000 Class A ordinary shares, no par value per share, were issued and outstanding.

EXPLANATORY NOTE

Blue Safari Group Acquisition Corp. (the “Company,” “we,” “us” or “our”) is filing this Amendment No. 1 to its Quarterly Report on Form 10-Q/A for (“Amendment No.1”) the quarterly period ended September 30, 2021 (this “Quarterly Report”) to amend certain terms in its Quarterly Report on Form 10-Q for the quarterly period September 30, 2021 originally filed with the Securities and Exchange Commission (the “SEC”) on November 22, 2021 (the “Original Quarterly Report”). This Amendment No. 1 is being filed solely to (i) correct an inadvertent error on the cover page regarding the number of issued and outstanding Class A ordinary shares from “4,941,393” to “6,100,000” and (ii) to correct the par value from “0.0001 par value” to “no par value” throughout the document.

i

TABLE OF CONTENTS

		Page
PART I.	FINANCIAL INFORMATION	1
Item 1.	Financial Statements (unaudited)	1
	Unaudited Condensed Balance Sheet as of September 30, 2021	1
	Unaudited Condensed Statements of Operations for the three months ended September 30, 2021 and for the period from February 23, 2021 (inception) through September 30, 2021	2
	Unaudited Condensed Statements of Changes in Stockholders’ Equity for the three months ended September 30, 2021 and for the period from February 23, 2021 (inception) through September 30, 2021	3
	Unaudited Condensed Statement of Cash Flows and for the period from February 23, 2021 (inception) through September 30, 2021	4
	Notes to Unaudited Condensed Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosure about Market Risks	17
Item 4.	Controls and Procedures	17
PART II.	OTHER INFORMATION	19
Item 1.	Legal Proceedings	19
Item 1A.	Risk Factors	19
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities	19
Item 3	Defaults Upon Senior Securities	20
Item 4	Mine Safety Disclosures	20
Item 5	Other Information	20
Item 6.	Exhibits	21
	Signatures	22

ii

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

BLUE SAFARI GROUP ACQUISITION CORP.

UNAUDITED CONDENSED BALANCE SHEET

SEPTEMBER 30, 2021

	September 30, 2021
Assets
Cash and cash equivalents	$	732,901
Prepaid Expenses		286,798
Total current assets		1,019,699
Cash held in Trust Account		58,075,877
Total Assets	$	59,095,576
Liabilities and Shareholders’ Equity
Accrued offering costs and expenses	$	207,049
Due to related party		301,930
Promissory note - related party		200,000
Total current liabilities		708,979
Deferred underwriters discount		2,012,500
Total liabilities		2,721,479
Commitments & Contingencies
Class A ordinary shares subject to possible redemption, 5,750,000 shares at redemption value		58,075,000
Shareholders’ Equity (Deficit):
Preference shares, no par value; 1,000,000 shares authorized; none issued and outstanding		—
Class A ordinary shares, no par value; 100,000,000 shares authorized; 350,000 issued and outstanding, excluding 5,750,000 shares subject to redemption		35
Class B ordinary shares, no par value; 10,000,000 shares authorized; 1,437,500 shares issued and outstanding		144
Additional paid-in capital		—
Accumulated deficit		(1,701,082)
Total shareholders’ equity (deficit)		(1,700,903)
Total Liabilities and Shareholders’ Equity (Deficit)	$	59,095,576

The accompanying notes are an integral part of these unaudited condensed financial statements.

1

BLUE SAFARI GROUP ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

	For the
	Three Months		For the Period from
	Ended		February 23, 2021
	September 30,		(Inception)
	2021		to September 30, 2021
Formation and operating costs	$	288,261	$	391,856
Loss from operations		(288,261)		(391,856)
Other income
Interest income		17		17
Interest income earned on Trust		877		877
Total other income		894		894
Net loss	$	(287,367)	$	(390,962)
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption		5,750,000		2,848,864
Basic and diluted net loss per share, Class A ordinary shares subject to possible redemption	$	(0.04)	$	(0.09)
Basic and diluted weighted average shares outstanding, Class B ordinary shares subject to possible redemption		1,787,500		1,552,102
Basic and diluted net loss per share, Class B ordinary shares subject to possible redemption	$	(0.04)	$	(0.09)

The accompanying notes are an integral part of these unaudited condensed financial statements.

2

BLUE SAFARI GROUP ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDER’S EQUITY (DEFICIT)

FOR THE PERIOD FROM FEBRUARY 23, 2021 (INCEPTION) THROUGH SEPTEMBER 30, 2021

	Preferred Shares			Class A Ordinary Shares			Class B Ordinary Shares			Additional		Accumulated		Stockholders'
	Shares	Amount		Shares	Amount		Shares	Amount		Paid-in Capital		Deficit		Equity (Deficit)
Balance as of February 23, 2021	—	$	—	—	$	—	—	$	—	$	—	$	—	$	—
Class B ordinary share issued to initial shareholder	—		—	—		—	1,437,500		144		24,857		—		25,001
Net loss	—		—	—		—	—		—		—		(8,010)		(8,010)
Balance as of March 31, 2021	—	$	—	—	$	—	1,437,500	$	144	$	24,857	$	(8,010)	$	16,991
Sale of 292,500 Private Placement Units on June 14, 2021	—		—	292,500		29	—		—		2,924,971		—		2,925,000
Issuance of representative shares	—		—	57,500		6	—		—		478,851		—		478,857
Accretion of carrying value to redemption value	—		—	—		—	—		—		(3,428,679)		(735,120)		(4,163,799)
To account for additional $.10 for the Units sold through public offering	—		—	—		—	—		—		—		(575,000)		(575,000)
Net loss	—		—	—		—	—		—		—		(95,585)		(95,585)
Balance as of June 30, 2021, as restated	—	$	—	350,000	$	35	1,437,500	$	144	$	—	$	(1,413,715)	$	(1,413,536)
Net loss	—		—	—		—	—		—		—		(287,367)		(287,367)
Balance as of September 30, 2021	—	$	—	350,000	$	35	1,437,500	$	144	$	—	$	(1,701,082)	$	(1,700,903)

The accompanying notes are an integral part of these unaudited condensed financial statements.

3

BLUE SAFARI GROUP ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS

	For the period
	from
	February 23, 2021
	(Inception) to
	September 30,
	2021
Cash flows from operating activities:
Net loss	$	(390,962)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation costs paid by Sponsor		7,169
Interest earned on cash and marketable securities held in Trust Account		(877)
Changes in current assets and liabilities:
Prepaid Assets		(286,798)
Due to related party		301,930
Accrued expenses		(227,623)
Net cash used in operating activities		(597,161)
Cash flows from investing activities:
Principal deposited in Trust Account		(58,075,000)
Net cash used in investing activities		(58,075,000)
Cash flows from financing activities:
Proceeds from initial public offering		50,000,006
Proceeds from private placement		2,925,000
Proceeds from overallotment, net of underwriter discount		7,500,569
Payment of deferred offering costs		(1,020,513)
Net cash provided by financing activities		59,405,062
Net change in cash		732,901
Cash, beginning of the period		—
Cash, end of the period	$	732,901
Supplemental disclosure of cash flow information:
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	$	25,001
Initial value of ordinary shares subject to possible redemption	$	58,075,000
Deferred underwriting commissions payable charged to additional paid in capital	$	2,012,500
Accrued deferred offering costs	$	523,017

The accompanying notes are an integral part of these unaudited condensed financial statements.

4

BLUE SAFARI GROUP ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

Note 1 — Organization and Business Operation

Blue Safari Group Acquisition Corp. (the “Company”) is newly incorporated blank check company incorporated as a British Virgin Island (“BVI”) business company on February 23, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any potential Business Combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any potential Business Combination target.

As of September 30, 2021, the Company had not commenced any operations. All activity for the period from February 23, 2021 (inception) through September 30, 2021 relates to the Company’s formation and the Proposed Public Offering (the “IPO”) as defined below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.

The Company’s Sponsor is BSG First Euro Investment Corp., a British Virgin Islands company (the “Sponsor”).

The registration statement for the Company’s IPO was declared effective on June 9, 2021 (the “Effective Date”). On June 14, 2021 the Company consummated the IPO of 5,750,000 units (the “Units”), including 750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), at $10.10 per Unit, generating gross proceeds of $58,075,000, which is discussed in Note 4.

Simultaneously with the closing of the IPO, the Company consummated the sale of 292,500 units (the “Private Placement Unit”), at a price of $10.00 per Private Placement Unit, generating gross proceeds of $2,925,000, which is discussed in Note 5.

Transaction costs of the IPO amounted to $4,163,799 consisting of $1,150,000 of underwriting discount, $2,012,500 of deferred underwriting discount, the fair value of the representative shares of $478,857 and $522,442 of other offering costs.

Upon the closing of the IPO, an aggregate of $10.10 per Unit sold in the IPO, or an aggregate of $58,075,000, was held in a Trust Account (“Trust Account”) and will be invested only in U.S. government treasury bills with a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Proposed Public Offering and the private placement will not be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period (defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-Business Combination activity and (iii) the redemption of all of the public shares if the Company is unable to complete the initial Business Combination within the Combination Period (defined below), subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the creditors, if any, which could have priority over the claims of the public shareholders.

5

The Company will provide the public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under the law or stock exchange listing requirement. The Company will provide the public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest, which interest shall be net of taxes payable, divided by the number of then outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is initially anticipated to be $10.10 per public share, which is subject to increase of up to an additional $0.20 per unit in the event that the Sponsor elects to extend the period of time to consummate a Business Combination.

The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

The Company will have 12 months from the closing of the IPO (the “Combination Period”) (or up to 18 months from the closing of the IPO if the Company extend the period of time to consummate a Business Combination by the full amount of time) to complete the initial Business Combination. If the Company has not completed the initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $50,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under British Virgin Islands law to provide for claims of creditors and the requirements of other applicable law.

The Sponsor, officers and directors have agreed to (i) to waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination and (ii) to waive their rights to liquidating distributions from the trust account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Combination Period). If the Company submits the initial Business Combination to the public shareholders for a vote, the insiders have agreed, pursuant to such letter agreement, to vote their founder shares, private placement shares and any public shares purchased during or after the IPO in favor of the initial Business Combination.

The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.10 per public share or (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third -party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy their indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. The Company has not asked the Sponsor to reserve for such obligations.

6

Liquidity and Management’s Plan

As of September 30, 2021, the Company had $732,901 in cash, and working capital of $310,720 (not taken into account tax obligations).

The Company’s liquidity needs prior to the consummation of the IPO were satisfied through the proceeds of $25,001 from the sale of the Founders Shares (as defined in Note 6), and loan proceeds from the Sponsor of $200,000 under the Note (Note 6). Subsequent from the consummation of the IPO, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the IPO and the Private Placement held outside of the Trust Account.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Risks and Uncertainties

Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 2 — Restatement of Previously Issued Financial Statements

In connection with the preparation of the Company’s financial statements as of September 30, 2021, management determined it should revise its previously reported financial statements. The Company previously determined the ordinary shares subject to possible redemption to be equal to the redemption value of $10.10 per ordinary shares while also taking into consideration its charter’s requirement that a redemption cannot result in net tangible assets being less than $5,000,001. Upon review of its financial statements for the period ended September 30, 2021, the Company reevaluated the classification of the ordinary shares and determined that the ordinary shares issued during the Initial Public Offering and pursuant to the exercise of the underwriters’ overallotment can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control under ASC 480-10-S99. Therefore, management concluded that the carrying value should include all ordinary shares subject to possible redemption, resulting in the ordinary shares subject to possible redemption being classified as temporary equity in its entirety. As a result, management has noted a reclassification adjustment related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the ordinary shares subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), retained earnings (accumulated deficit) and ordinary shares.

In connection with the restatement of the ordinary shares subject to redemption, the Company also restated its earnings per share calculation to allocate net income (loss) proportionally to ordinary shares subject to redemption and those that are not subject to redemption. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of ordinary shares share pro rata in the income (loss) of the Company.

There has been no change in the Company’s total assets, liabilities or operating results.

7

The impact of the revision on the Company’s financial statements are reflected in the following table:

	As Reported		Adjustments		As Restated
Balance Sheet as of June 14, 2021 (per Form 8-K filed on June 21, 2021)
Ordinary shares subject to possible redemption ($)	$	51,793,274	$	6,281,726	$	58,075,000
Ordinary shares Class A, no par value		97		(62)		35
Ordinary shares Class B, no par value		144		—		144
Additional Paid-in Capital		5,016,544		(5,016,544)		—
Accumulated Deficit		(16,776)		(1,265,120)		(1,281,896)
Total Shareholders' Equity (Deficit)	$	5,000,009	$	(6,281,726)	$	(1,281,717)
Number of shares subject to redemption		5,128,047		621,953		5,750,000
Balance Sheet as of June 30, 2021 (per Form 10-Q filed on August 18, 2021)
Ordinary shares subject to possible redemption ($)	$	51,661,459	$	6,413,541	$	58,075,000
Ordinary shares Class A, no par value		98		(63)		35
Ordinary shares Class B, no par value		144		—		144
Additional Paid-in Capital		5,103,358		(5,103,358)		—
Accumulated Deficit		(103,595)		(1,310,120)		(1,413,715)
Total Shareholders' Equity (Deficit)	$	5,000,005	$	(6,413,541)	$	(1,413,536)
Number of shares subject to redemption		5,114,996		635,004		5,750,000

Unaudited Statements of Operations
For the three ended June 30, 2021 and For the period from
February 23, 2021 (Inception) to June 30, 2021 as adjusted for
Temporary Equity related to Public Shares	As Reported		Adjustments		As Restated
Three months ended June 30, 2021
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption		957,843		116,333		1,074,176
Basic and diluted weighted average shares outstanding, ordinary shares not subject to redemption		1,619,217		(181,717)		1,437,500
Basic and diluted net loss per share per ordinary share subject to possible redemption	$	0.00	$	(0.04)	$	(0.04)
Basic and diluted net loss per share per nonredeemable ordinary share	$	(0.06)	$	0.02	$	(0.04)
For the period from February 23, 2021 (Inception) to June 30, 2021
Basic and diluted weighted average shares outstanding ordinary shares subject to redemption		5,127,279		(4,363,607)		763,672
Basic and diluted weighted average shares outstanding ordinary shares not subject to redemption		1,566,689		(230,263)		1,336,426
Basic and diluted net loss per share per ordinary share subject to possible redemption	$	0.00	$	(0.05)	$	(0.05)
Basic and diluted net loss per share per nonredeemable ordinary share	$	(0.07)	$	0.02	$	(0.05)

Unaudited Statements of Cash Flows
For the six months ended June 30, 2021
as adjusted for Temporary Equity related to Public Shares	As Reported		Adjustments		As Restated
Initial value of shares subject to possible redemption	$	51,661,459	$	6,413,541	$	58,075,000

8

Note 3 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021.

Offering Costs Associated with IPO

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to shareholders’ equity upon the completion of the IPO. Accordingly, as of September 30, 2021, offering costs in the aggregate of $4,163,799 have been charged to shareholders’ equity (consisting of $1,150,000 of underwriting discount, $2,012,500 of deferred underwriting discount, the fair value of the representative shares of $478,857 and $522,442 of other offering costs.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.

9

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP stablishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Cash Held in Trust Account

At September 30, 2021, the Company had $58,075,877 in cash held in the Trust Account consisting of cash held in a money market fund

Due to Related Party

The balance of $301,930 is represented by $7,333 accrued for the administrative support services provided by the Sponsor commencing on the date the securities of the Company are first listed on the Nasdaq Capital Market, and $294,597 of accrued expenses paid by the Sponsor on behalf of the Company.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2021, 5,750,000 shares of Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

10

Net Income (loss) Per Ordinary Share

The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of ordinary shares:

	For the Three Months Ended September 30,						For the Period from February 23, 2021
	2021						(Inception) to September 30, 2021
			non-						non-
	redeemable		redeemable				redeemable		redeemable
	Class A		Class A		Class B		Class A		Class A		Class B
NUMERATOR
Allocation of net loss	$	(219,219)	$	(13,344)	$	(54,805)	$	(253,080)	$	(15,405)	$	(122,477)
DENOMINATOR
Weighted average shares outstanding		5,750,000		350,000		1,437,500		2,848,864		173,409		1,378,693
Basic and diluted net loss per share	$	(0.04)	$	(0.04)	$	(0.04)	$	(0.09)	$	(0.09)	$	(0.09)

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the British Virgin Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

The Company is considered to be a British Virgin Islands business company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands or the United States. As such, the Company’s tax provision was zero for the period presented.

Concentration of credit risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative

11

scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Note 4 — Initial Public Offering

On June 14, 2021, Company consummated its IPO and sold 5,750,000 Units, including 750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment. Each Unit consists of one ordinary share (“Ordinary Share”) and one right (“Right”) to receive one-tenth of one Ordinary Share upon the consummation of an initial business combination. The Units were sold at a price of $10.10 per unit, generating gross proceeds to the Company of $58,075,000.

All of the 5,750,000 Class A ordinary share sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s certificate of incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.

The Class A ordinary share is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they occur. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable ordinary shares resulted in charges against additional paid-in capital and accumulated deficit.

As of September 30, 2021, the ordinary shares reflected on the balance sheet are reconciled in the following table:

Gross proceeds from IPO	$	58,075,000
Less:
Ordinary shares issuance costs		(4,163,799)
Plus:
Accretion of carrying value to redemption value		4,163,799
Contingently redeemable ordinary shares	$	58,075,000

Note 5 — Private Placement

Simultaneously with the closing of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of an aggregate 292,500 Units (“Private Placement Units”), which included the additional 22,500 Private Placement Units sold pursuant to the full exercise of the underwriters’ option to cover the over-allotment.

The Private Placement Units and their component securities will not be transferable, assignable or salable until 30 days after the consummation of the initial Business Combination except to permitted transferees, and they will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

12

Note 6 — Related Party Transactions

Founder Shares

On February 23, 2021 and March 4, 2021, the Company’s Sponsor paid $25,001, or approximately $0.017 per share, to cover certain of the offering and formation costs in exchange for an aggregate of 1,437,500 Class B ordinary shares (“Founder shares’), with no par value per share, 187,500 of which are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised. On June 14, 2021, the underwriter exercised the over-allotment option in full, hence, the 187,500 Founder Shares that are no longer subject to forfeiture.

The Company’s initial shareholders have agreed not to transfer, assign or sell any of its founder shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination or (B) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after the initial Business Combination that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property (except as described herein under “Principal Shareholders — Transfers of Founder Shares and Private Placement Units”). (the “Lock-up”).

Promissory Note — Related Party

On March 1, 2021, the Company issued the Promissory Note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $200,000. The Promissory Note is non-interest bearing and payable promptly after the date on which the Maker consummates the IPO of its securities. As of September 30, 2021, the Company had borrowed $200,000 under the promissory note.

Working Capital Loans

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,150,000 of the Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. The units would be identical to the Private Placement Units. As of September 30, 2021, no such Working Capital Loans were outstanding.

Note 7 — Commitments & Contingencies

Registration Rights

The holders of the founder shares, Private Placement Units, shares being issued to the underwriters of the Proposed Public Offering, and units that may be issued on conversion of Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Proposed Public Offering requiring the Company to register such securities for resale (in the case of the founder shares, only after conversion to the Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act.

Underwriting Agreement

The underwriters have a 45-day option from June 14, 2021 to purchase up to an additional 750,000 Units, consisting of 750,000 Class A ordinary shares and 750,000 rights to cover over-allotments, if any.

13

On June 14, 2021, the underwriter fully exercised the over-allotment option to purchase 750,000 Units, and paid an underwriting commission in aggregate of $1,150,000. Additionally, the underwriters will be entitled to a deferred underwriting commissions of 3.5% of the gross proceeds of the IPO held in the Trust Account, or $2,012,500 upon the completion of the Company’s initial Business Combination subject to the terms of the underwriting agreement.

Representative’s Ordinary Shares

The Company issued to Maxim Partners LLC and/or its designees, 57,500 shares upon the consummation of the IPO, the fair value of which is $575. Maxim has agreed not to transfer, assign or sell any such shares until the completion of our initial business combination. In addition, Maxim has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of our initial business combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete our initial business combination within 12 months from the closing of the IPO, or up to 18 months from the closing of the IPO if the Company extends the period of time to consummate a business combination.

The shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales in this offering pursuant to FINRA Rule 5110(e)(1). Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statement of which the prospectus forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the registration statement of which the prospectus forms a part except to any underwriter and selected dealer participating in the offering and their officers, partners, registered persons or affiliates.

Right of First Refusal

For a period beginning on the closing of the IPO and ending 12 months from the closing of a business combination, the Company has granted Maxim a right of first refusal to act as lead-left book running manager and lead left placement agent for any and all future private or public equity, equity-linked, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(g)(6)(A), such right of first refusal shall not have a duration of more than three years from the commencement of sales in the IPO.

Note 8 — Shareholders’ Equity

Preference Shares — The Company is authorized to issue a total of 1,000,000 preferred shares with no par value. As of September 30, 2021, there were no preference shares issued or outstanding.

Class A Ordinary Shares — The Company is authorized to issue a total of 100,000,000 Class A ordinary shares with no par value. As of September 30, 2021, there were 350,000 Class A ordinary shares outstanding, excluding 5,750,000 Class A ordinary shares subject to possible redemption.

Class B Ordinary Shares—The Company is authorized to issue a total of 10,000,000 Class B ordinary shares with no par value. As of September 30, 2021, there were 1,437,500 Class B ordinary shares issued and outstanding.

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

14

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References to the “Company,” “BSGA,” “our,” “us” or “we” refer to Blue Safari Group Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other U.S. Securities and Exchange Commission (“SEC”) filings.

Overview

We are a blank check company incorporated in the British Virgin Islands as a business company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of this offering and the private placement of the private placement units, the proceeds of the sale of our securities in connection with our initial business combination, our shares, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Recent Developments

On November 18, 2021, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among us, Blue Safari Mini Corp., an exempted company incorporated with limited liability under the laws of the Cayman Islands and our wholly-owned subsidiary (“Merger Sub”), and Bitdeer Technologies Holding Company, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“Bitdeer”).

Pursuant to the Merger Agreement, the parties thereto will enter into a business combination transaction (the “Business Combination”) by which Merger Sub will merge with and into Bitdeer with Bitdeer being the surviving entity and becoming our wholly-owned subsidiary (the “Merger” and, together with the other transactions contemplated by the Merger Agreement, the “Transactions”). The Merger Agreement and the Transactions were unanimously approved by the boards of directors of each of Blue Safari and Bitdeer.

The Business Combination is expected to be consummated after obtaining the required approval by the shareholders of Blue Safari and Bitdeer and the satisfaction of certain other customary closing conditions.  For more information, see the Current Report on Form 8-K dated November 18, 2021.

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities from inception through September 30, 2021 were organizational activities and those necessary to prepare for the Initial Public Offering, and, following our initial public offering, identifying a target business with which to engage in a Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We expect to generate non-operating income in the

15

form of interest income on marketable securities held after the Initial Public Offering. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

For the quarter ended September 30, 2021, we had a net loss of $287,367, which consists of formation and operation costs amounting to $288,361, partially offset by the interest income earned on Trust and operating accounts amounting to $894.

For the period from February 23, 2021 (inception) to September 30, 2021, we had a net loss of $390,962, which consists of formation and operation costs amounting to $391,856, partially offset by the interest income earned on Trust and operating accounts amounting to $894.

Liquidity and Capital Resources

On June 9, 2021, Blue Safari Group Acquisition Corp. (the “Company”) consummated the IPO of 5,000,000 units (the “Units”). Each Unit consists of one ordinary share (“Ordinary Share”) and one right (“Right”) to receive one-tenth of one Ordinary Share upon the consummation of an initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $50,000,000. The Company granted the underwriters a 45-day option to purchase up to 750,000 additional Units to cover over-allotments, if any, which the underwriters exercised in full simultaneously with the consummation of the IPO. The total aggregate issuance by the Company of 5,750,000 units at a price of $10.00 per unit resulted in a total gross proceeds of $57,500,000.

As of June 9, 2021, a total of $58,075,000 of the net proceeds from the IPO and the Private Placement (as defined below) were deposited in a trust account established for the benefit of the Company’s public shareholders. Simultaneously with the closing of the IPO, the Company consummated the private placement (“Private Placement”) with BSG First Euro Investment Corp., the Company’s sponsor, of 292,500 units (the “Private Units”) at a price of $10.00 per Private Unit, generating total proceeds of $2,925,000. The Private Units are identical to the Units sold in the IPO. Additionally, such initial purchasers agreed not to transfer, assign or sell any of the Private Units or underlying securities (except in limited circumstances, as described in the Registration Statement) until 30 days after the completion of the Company’s initial business combination. Such initial purchasers were granted certain demand and piggyback registration rights in connection with the purchase of the Private Units. The Private Units were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.

Following the Initial Public Offering and the sale of the Private Units, a total of $58,075,000 was placed in the Trust Account, and we had $884,500 of cash held outside of the Trust Account, after payment of costs related to the Initial Public Offering, and available for working capital purposes. We incurred $4,163,799 in transaction costs, including $1,150,000 of underwriting fees, $2,012,500 of deferred underwriting fees, the fair value of the representative shares of $478,857, and $522,442 of other offering costs.

For the quarter ended September 30, 2021, there was $597,161 of cash used in operating activities. Net loss of $390,962 was affected by noncash charges related to formation costs paid by Sponsor in exchange for issuance of Class B ordinary shares of $25,001 and interest earned on cash and marketable securities held in Trust Account amounting to $877.

As of September 30, 2021, we had $732,901 of cash on hand. We intend to use the funds held outside the Trust Account for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment.

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination

16

are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our Business Combination. If we are unable to complete our Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non- financial assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities other than an agreement to pay our Sponsor a monthly fee of $10,000 for office space, utilities and secretarial and administrative support. We began incurring these fees on June 14, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation.

The underwriters are entitled to a deferred fee of 3.5% of the gross proceeds of the Initial Public Offering, or $2,012,500. The deferred fee will be payable in cash to the underwriters solely in the event that we complete a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Recent Accounting Standards

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As smaller reporting company we are not required to make disclosures under this Item.

Item 4. Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

17

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of September 30, 2021, due to the previous material weakness in our internal control over financial reporting described in Item 4. Controls and Procedures included in our Quarterly Report on Form 10-Q as filed with the SEC on May 25, 2021, and due to the revisions of our March 23, 2021, March 31, 2021, and June 30, 2021 financial statements (the "revisions") regarding the classification of redeemable Class A Shares, as described below, which combined, constitutes a material weakness in our internal control over financial reporting. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our unaudited interim financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

Regarding the revisions to the June 30, 2021 quarterly financial statements included in the Company's Form 10-Qs, as filed with the SEC on August 18, 2021, as well as the Company's balance sheet included on the Company's Form 8-K, as filed with the SEC on June 21, 2021, certain redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of the Class A ordinary shares in permanent equity. The Company revised its financial statements to classify all Class A ordinary shares as temporary equity and any related impact, as the threshold in its charter would not change the nature of the underlying shares as redeemable and thus would be required to be disclosed outside of permanent equity.

It is noted that the non-cash adjustments to the financial statement do not impact the amounts previously reported for our cash and cash equivalents or total assets. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our unaudited interim financial statements were prepared in accordance with U.S. generally accepted accounting principles.

18

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors.

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks previously disclosed in our Form 8-K filed with the SEC on June 21, 2021 and our Form 10-Q filed with the SEC on August 18, 2021. Any of those factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of the Form 8-K and Form 10-Q, there have been no material changes to the risk factors disclosed in our Form 8-K filed with the SEC on June 21, 2021 and our Form 10-Q filed with the SEC on August 18, 2021, except as disclosed below. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

We have identified a material weakness in our internal control over financial reporting. If we are unable to develop and maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results, and we may face litigation as a result.

In connection with the preparation of the Company’s financial statements as of September 30, 2021, the Company reevaluated the classification of the Class A ordinary shares subject to possible redemption. After consultation with the Company’s independent registered public accounting firm, the Company’s management and the Audit Committee concluded that the previously issued audited balance sheet dated as of June 14, 2021, which was related to our initial public offering, and the previously issued audited balance sheet dated as of June 30, 2021 should be restated to report all Class A ordinary shares subject to possible redemption as temporary equity.

As part of such process, we identified a material weakness in our internal control over financial reporting related to the accounting for complex financial instruments and application of ASC 480-10-S99-3A to our accounting classification of Class A ordinary shares subject to possible redemption. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented, or detected and corrected on a timely basis.

Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. We continue to evaluate steps to remediate the material weakness. These remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately have the intended effects.

A material weakness could limit our ability to prevent or detect a misstatement of our accounts or disclosures that could result in a material misstatement of our annual or interim financial statements. In such a case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting, our securities price may decline and we may face litigation as a result. We cannot assure you that the measures we have taken to date, or any measures we may take in the future, will be sufficient to avoid potential future material weaknesses.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The registration statement (the “Registration Statement”) for our Initial Public Offering was declared effective on June 9, 2021. On June 14, 2021, we consummated the IPO of 5,000,000 units (the “Units”). Each Unit consists of one ordinary share (“Ordinary Share”) and one right (“Right”) to receive one-tenth of one Ordinary Share upon the consummation of an initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $50,000,000. The Company granted the underwriters a 45-day option to purchase up to 750,000 additional Units to cover over-allotments, if any, which the underwriters exercised in full simultaneously with the consummation of the IPO. The total aggregate issuance by the Company of 5,750,000 units at a purchase price

19

of $10.00 per unit resulted in a total gross proceeds of $57,500,000, and offering costs of approximately $3.7 million, inclusive of approximately $2 million in deferred underwriting commissions.

Simultaneously with the closing of the IPO, the Company consummated the Private Placement with BSG First Euro Investment Corp., the Company’s sponsor, of 292,500 Private Units at a price of $10.00 per Private Unit, generating total proceeds of $2,925,000.The Private Units were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.

Upon the closing of the Initial Public Offering and the Private Placement (including the exercise of the over-allotment option) $57,500,000 ($10.00 per share) of the net proceeds of the sale of the Public Shares in the Initial Public Offering and the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and held as cash or invested only in U.S. “government securities,” within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less, or in money market funds meeting certain conditions under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

We paid a total of approximately $1 million in underwriting discounts and commissions (not including the 3.5% deferred underwriting commission payable at the consummation of the initial business combination) and approximately $0.5 million for other costs and expenses related to our formation and the Initial Public Offering.

For a description of the use of the proceeds generated in our IPO, see Part I, Item 2 of this Form 10-Q.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

20

Item 6. Exhibits.

Exhibit Number	Description
31.1*	Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d- 14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification of Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit)

* These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

21

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated:	December 10, 2021	BLUE SAFARI GROUP ACQUISITION CORP.
		By:	/s/ Alex Yamashita
		Name:	Alex Yamashita
		Title:	Chief Executive Officer
			(Principal Executive Officer)
		By:	/s/ Naphat Sirimongkolkasem
		Name:	Naphat Sirimongkolkasem
		Title:	Chief Financial Officer
			(Principal Financial and Accounting Officer)

22

EX-31.1

EXHIBIT 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, AlexYamashita, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 of Blue Safari Group Acquisition Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. [Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: December 10, 2021	By:	/s/ Alex Yamashita
		Alex Yamashita
		Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Naphat Sirimongkolkasem, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 of Blue Safari Group Acquisition Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. [Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: December 10, 2021	By:	/s/ Naphat Sirimongkolkasem
		Naphat Sirimongkolkasem
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Blue Safari Group  Acquisition Corp. (the “Company”) on Form 10-   Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, AlexYamashita, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: December 10, 2021	/s/ Alex Yamashita
	Name:	Alex Yamashita
	Title:	Chief Executive Officer
		(Principal Executive Officer)

EX-32.2

XHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Blue Safari Group  Acquisition Corp. (the “Company”) on Form 10-   Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “ Report”), I, Naphat Sirimongkolkasem, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: December 10, 2021	/s/ Naphat Sirimongkolkasem
	Name:	Naphat Sirimongkolkasem
	Title:	Chief Financial Officer and Treasurer
		(Principal Financial and Accounting Officer)

XML

Document and Entity Information - shares	7 Months Ended
	Sep. 30, 2021	Dec. 10, 2021
Document Information [Line Items]
Document Type	10-Q/A
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Entity Registrant Name	Blue Safari Group Acquisition Corp
Entity Incorporation, State or Country Code	D8
Entity File Number	001-40473
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	Cheung Kong Center,
Entity Address, Address Line Two	58th Floor, Unit 5801
Entity Address, Address Line Three	2 Queens Road Central
Entity Address, City or Town	Central
Entity Address, Country	HK
City Area Code	+852
Local Phone Number	9258 9728
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		6,100,000
Entity Central Index Key	0001853084
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	true
Transition Report	true
Units, each consisting of one Class A ordinary share, with no par value, and one right to receive one-tenth of one Class A ordinary share
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, with no par value, and one right to receive one-tenth of one Class A ordinary share
Trading Symbol	BSGAU
Security Exchange Name	NASDAQ
Class A ordinary shares included as part of the units
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares included as part of the units
Trading Symbol	BSGA
Security Exchange Name	NASDAQ
Rights included as part of the units
Document Information [Line Items]
Title of 12(b) Security	Rights included as part of the units
Trading Symbol	BSGAR
Security Exchange Name	NASDAQ

XML

UNAUDITED CONDENSED BALANCE SHEET	Sep. 30, 2021 USD ($)
Assets
Cash and cash equivalents	$ 732,901
Prepaid Expenses	286,798
Total current assets	1,019,699
Cash held in Trust Account	58,075,877
Total Assets	59,095,576
Liabilities and Shareholders' Equity
Accrued offering costs and expenses	207,049
Due to related party	301,930
Promissory note - related party	200,000
Total current liabilities	708,979
Deferred underwriters discount	2,012,500
Total liabilities	2,721,479
Commitments & Contingencies
Shareholders' Equity (Deficit):
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	0
Accumulated deficit	(1,701,082)
Total shareholders' equity (deficit)	(1,700,903)
Total Liabilities and Shareholders' Equity (Deficit)	59,095,576
Class A Ordinary Shares
Liabilities and Shareholders' Equity
Contingently redeemable ordinary shares	58,075,000
Class A ordinary shares subject to possible redemption
Liabilities and Shareholders' Equity
Contingently redeemable ordinary shares	58,075,000
Class A ordinary shares not subject to possible redemption
Shareholders' Equity (Deficit):
Common stock	35
Class B Ordinary Shares
Shareholders' Equity (Deficit):
Common stock	$ 144

XML

UNAUDITED CONDENSED BALANCE SHEET (Parenthetical) - $ / shares	Sep. 30, 2021	Jun. 30, 2021	Jun. 14, 2021	Mar. 31, 2021
Preferred stock, par value, (per share)	$ 0
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Temporary equity, shares outstanding		5,750,000	5,750,000
Class A Ordinary Shares
Common shares, par value	$ 0	$ 0	$ 0
Common shares, shares authorized	100,000,000
Common shares, shares issued	350,000
Common shares, shares outstanding	350,000
Temporary equity, shares outstanding	5,750,000
Class A ordinary shares subject to possible redemption
Temporary equity, shares outstanding	5,750,000
Class A ordinary shares not subject to possible redemption
Common shares, shares authorized	100,000,000
Common shares, shares outstanding	350,000
Class B Ordinary Shares
Common shares, par value	$ 0	$ 0	$ 0
Common shares, shares authorized	10,000,000
Common shares, shares issued	1,437,500			1,437,500
Common shares, shares outstanding	1,437,500

XML

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	7 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Formation and operating costs	$ 288,261	$ 391,856
Loss from operations	(288,261)	(391,856)
Other income
Interest income	17	17
Interest income earned on Trust	877	877
Total other income	894	894
Net loss	$ (287,367)	$ (390,962)
Class A ordinary shares subject to possible redemption
Other income
Basic weighted average shares outstanding	5,750,000	2,848,864
Diluted weighted average shares outstanding	5,750,000	2,848,864
Basic net loss per common share	$ (0.04)	$ (0.09)
Diluted net loss per common share	$ 0.00	$ 0.00
Ordinary shares not subject to redemption
Other income
Basic weighted average shares outstanding	1,787,500	1,552,102
Diluted weighted average shares outstanding	1,787,500	1,552,102
Basic net loss per common share	$ (0.04)	$ (0.09)
Diluted net loss per common share	$ (0.04)	$ (0.09)

XML

UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER'S EQUITY (DEFICIT) - USD ($)	Class A ordinary shares not subject to possible redemption Common Stock	Class B Ordinary Shares Common Stock	Class A ordinary shares subject to possible redemption	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Feb. 22, 2021				$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class B ordinary share issued to initial shareholder		$ 144
Class B ordinary share issued to initial shareholder (in shares)		1,437,500
Net loss						$ (8,010)
Balance at the end at Mar. 31, 2021		$ 144		24,857	(8,010)	16,991
Balance at the end (in shares) at Mar. 31, 2021		1,437,500
Balance at the beginning at Feb. 22, 2021				0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class B ordinary share issued to initial shareholder				24,857	0	25,001
Accretion of carrying value to redemption value			$ 4,163,799
Net loss				0	(8,010)	(390,962)
Balance at the end at Sep. 30, 2021	$ 35	$ 144		0	(1,701,082)	(1,700,903)
Balance at the end (in shares) at Sep. 30, 2021	350,000	1,437,500
Balance at the beginning at Mar. 31, 2021		$ 144		24,857	(8,010)	16,991
Balance at the beginning (in shares) at Mar. 31, 2021		1,437,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of 292,500 Private Placement Units on June 14, 2021	$ 29			2,924,971	0	2,925,000
Sale of 292,500 Private Placement Units on June 14, 2021 (in shares)	292,500
Issuance of representative shares	$ 6			478,851	0	478,857
Issuance of representative shares (in shares)	57,500
Accretion of carrying value to redemption value				(3,428,679)	(735,120)	(4,163,799)
To account for additional $.10 for the Units sold through public offering				0	(575,000)	(575,000)
Net loss				0	(95,585)	(95,585)
Balance at the end at Jun. 30, 2021	$ 35	$ 144		0	(1,413,715)	(1,413,536)
Balance at the end (in shares) at Jun. 30, 2021	350,000	1,437,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Underwriters' discount						1,150,000
Other offering expenses						522,442
Net loss				0	(287,367)	(287,367)
Balance at the end at Sep. 30, 2021	$ 35	$ 144		$ 0	$ (1,701,082)	(1,700,903)
Balance at the end (in shares) at Sep. 30, 2021	350,000	1,437,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Deferred underwriter Discount						$ (2,012,500)

XML

UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER'S EQUITY (DEFICIT) (Parenthetical) - shares	Jun. 30, 2021	Jun. 14, 2021
UNAUDITED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER'S EQUITY (DEFICIT)
Sale of Private Placement Warrants (in shares)	0.10	292,500

XML

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS	7 Months Ended
	Sep. 30, 2021 USD ($)
Cash flows from operating activities:
Net loss	$ (390,962)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation costs paid by Sponsor	7,169
Interest earned on cash and marketable securities held in Trust Account	(877)
Changes in current assets and liabilities:
Prepaid Assets	(286,798)
Due to related party	301,930
Accrued expenses	(227,623)
Net cash used in operating activities	(597,161)
Cash flows from investing activities:
Principal deposited in Trust Account	(58,075,000)
Net cash used in investing activities	(58,075,000)
Cash flows from financing activities:
Proceeds from initial public offering	50,000,006
Proceeds from private placement	2,925,000
Proceeds from over allotment net of under writer discount	7,500,569
Payment of deferred offering costs	(1,020,513)
Net cash provided by financing activities	59,405,062
Net change in cash	732,901
Cash, beginning of the period	0
Cash, end of the period	732,901
Supplemental disclosure of cash flow information:
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	25,001
Initial value of ordinary shares subject to possible redemption	58,075,000
Deferred underwriting commissions payable charged to additional paid in capital	2,012,500
Accrued deferred offering costs	$ 523,017

XML

Organization and Business Operation

7 Months Ended

Sep. 30, 2021

Organization and Business Operation

Organization and Business Operation

Note 1 — Organization and Business Operation

Blue Safari Group Acquisition Corp. (the “Company”) is newly incorporated blank check company incorporated as a British Virgin Island (“BVI”) business company on February 23, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company has not selected any potential Business Combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any potential Business Combination target.

As of September 30, 2021, the Company had not commenced any operations. All activity for the period from February 23, 2021 (inception) through September 30, 2021 relates to the Company’s formation and the Proposed Public Offering (the “IPO”) as defined below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end.

The Company’s Sponsor is BSG First Euro Investment Corp., a British Virgin Islands company (the “Sponsor”).

The registration statement for the Company’s IPO was declared effective on June 9, 2021 (the “Effective Date”). On June 14, 2021 the Company consummated the IPO of 5,750,000 units (the “Units”), including 750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), at $10.10 per Unit, generating gross proceeds of $58,075,000, which is discussed in Note 4.

Simultaneously with the closing of the IPO, the Company consummated the sale of 292,500 units (the “Private Placement Unit”), at a price of $10.00 per Private Placement Unit, generating gross proceeds of $2,925,000, which is discussed in Note 5.

Transaction costs of the IPO amounted to $4,163,799 consisting of $1,150,000 of underwriting discount, $2,012,500 of deferred underwriting discount, the fair value of the representative shares of $478,857 and $522,442 of other offering costs.

Upon the closing of the IPO, an aggregate of $10.10 per Unit sold in the IPO, or an aggregate of $58,075,000, was held in a Trust Account (“Trust Account”) and will be invested only in U.S. government treasury bills with a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Proposed Public Offering and the private placement will not be released from the Trust Account until the earliest of (i) the completion of the initial Business Combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period (defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-Business Combination activity and (iii) the redemption of all of the public shares if the Company is unable to complete the initial Business Combination within the Combination Period (defined below), subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the creditors, if any, which could have priority over the claims of the public shareholders.

The Company will provide the public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under the law or stock exchange listing requirement. The Company will provide the public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest, which interest shall be net of taxes payable, divided by the number of then outstanding public shares, subject to the limitations described herein. The amount in the Trust Account is initially anticipated to be $10.10 per public share, which is subject to increase of up to an additional $0.20 per unit in the event that the Sponsor elects to extend the period of time to consummate a Business Combination.

The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

The Company will have 12 months from the closing of the IPO (the “Combination Period”) (or up to 18 months from the closing of the IPO if the Company extend the period of time to consummate a Business Combination by the full amount of time) to complete the initial Business Combination. If the Company has not completed the initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $50,000 of interest to pay dissolution expenses) divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under British Virgin Islands law to provide for claims of creditors and the requirements of other applicable law.

The Sponsor, officers and directors have agreed to (i) to waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination and (ii) to waive their rights to liquidating distributions from the trust account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Combination Period). If the Company submits the initial Business Combination to the public shareholders for a vote, the insiders have agreed, pursuant to such letter agreement, to vote their founder shares, private placement shares and any public shares purchased during or after the IPO in favor of the initial Business Combination.

The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.10 per public share or (ii) such lesser amount per public share held in the trust account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third -party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy their indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. The Company has not asked the Sponsor to reserve for such obligations.

Liquidity and Management’s Plan

As of September 30, 2021, the Company had $732,901 in cash, and working capital of $310,720 (not taken into account tax obligations).

The Company’s liquidity needs prior to the consummation of the IPO were satisfied through the proceeds of $25,001 from the sale of the Founders Shares (as defined in Note 6), and loan proceeds from the Sponsor of $200,000 under the Note (Note 6). Subsequent from the consummation of the IPO, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the IPO and the Private Placement held outside of the Trust Account.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Risks and Uncertainties

Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML

Restatement of Previously Issued Financial Statements

7 Months Ended

Sep. 30, 2021

Restatement of Previously Issued Financial Statements

Revision of Previously Issued Financial Statements

Note 2 — Restatement of Previously Issued Financial Statements

In connection with the preparation of the Company’s financial statements as of September 30, 2021, management determined it should revise its previously reported financial statements. The Company previously determined the ordinary shares subject to possible redemption to be equal to the redemption value of $10.10 per ordinary shares while also taking into consideration its charter’s requirement that a redemption cannot result in net tangible assets being less than $5,000,001. Upon review of its financial statements for the period ended September 30, 2021, the Company reevaluated the classification of the ordinary shares and determined that the ordinary shares issued during the Initial Public Offering and pursuant to the exercise of the underwriters’ overallotment can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control under ASC 480-10-S99. Therefore, management concluded that the carrying value should include all ordinary shares subject to possible redemption, resulting in the ordinary shares subject to possible redemption being classified as temporary equity in its entirety. As a result, management has noted a reclassification adjustment related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the ordinary shares subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), retained earnings (accumulated deficit) and ordinary shares.

In connection with the restatement of the ordinary shares subject to redemption, the Company also restated its earnings per share calculation to allocate net income (loss) proportionally to ordinary shares subject to redemption and those that are not subject to redemption. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of ordinary shares share pro rata in the income (loss) of the Company.

There has been no change in the Company’s total assets, liabilities or operating results.

The impact of the revision on the Company’s financial statements are reflected in the following table:

	As Reported		Adjustments		As Restated
Balance Sheet as of June 14, 2021 (per Form 8-K filed on June 21, 2021)
Ordinary shares subject to possible redemption ($)	$	51,793,274	$	6,281,726	$	58,075,000
Ordinary shares Class A, no par value		97		(62)		35
Ordinary shares Class B, no par value		144		—		144
Additional Paid-in Capital		5,016,544		(5,016,544)		—
Accumulated Deficit		(16,776)		(1,265,120)		(1,281,896)
Total Shareholders' Equity (Deficit)	$	5,000,009	$	(6,281,726)	$	(1,281,717)
Number of shares subject to redemption		5,128,047		621,953		5,750,000
Balance Sheet as of June 30, 2021 (per Form 10-Q filed on August 18, 2021)
Ordinary shares subject to possible redemption ($)	$	51,661,459	$	6,413,541	$	58,075,000
Ordinary shares Class A, no par value		98		(63)		35
Ordinary shares Class B, no par value		144		—		144
Additional Paid-in Capital		5,103,358		(5,103,358)		—
Accumulated Deficit		(103,595)		(1,310,120)		(1,413,715)
Total Shareholders' Equity (Deficit)	$	5,000,005	$	(6,413,541)	$	(1,413,536)
Number of shares subject to redemption		5,114,996		635,004		5,750,000

Unaudited Statements of Operations
For the three ended June 30, 2021 and For the period from
February 23, 2021 (Inception) to June 30, 2021 as adjusted for
Temporary Equity related to Public Shares	As Reported		Adjustments		As Restated
Three months ended June 30, 2021
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption		957,843		116,333		1,074,176
Basic and diluted weighted average shares outstanding, ordinary shares not subject to redemption		1,619,217		(181,717)		1,437,500
Basic and diluted net loss per share per ordinary share subject to possible redemption	$	0.00	$	(0.04)	$	(0.04)
Basic and diluted net loss per share per nonredeemable ordinary share	$	(0.06)	$	0.02	$	(0.04)
For the period from February 23, 2021 (Inception) to June 30, 2021
Basic and diluted weighted average shares outstanding ordinary shares subject to redemption		5,127,279		(4,363,607)		763,672
Basic and diluted weighted average shares outstanding ordinary shares not subject to redemption		1,566,689		(230,263)		1,336,426
Basic and diluted net loss per share per ordinary share subject to possible redemption	$	0.00	$	(0.05)	$	(0.05)
Basic and diluted net loss per share per nonredeemable ordinary share	$	(0.07)	$	0.02	$	(0.05)

Unaudited Statements of Cash Flows
For the six months ended June 30, 2021
as adjusted for Temporary Equity related to Public Shares	As Reported		Adjustments		As Restated
Initial value of shares subject to possible redemption	$	51,661,459	$	6,413,541	$	58,075,000

XML

Summary of Significant Accounting Policies

7 Months Ended

Sep. 30, 2021

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Note 3 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021.

Offering Costs Associated with IPO

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to shareholders’ equity upon the completion of the IPO. Accordingly, as of September 30, 2021, offering costs in the aggregate of $4,163,799 have been charged to shareholders’ equity (consisting of $1,150,000 of underwriting discount, $2,012,500 of deferred underwriting discount, the fair value of the representative shares of $478,857 and $522,442 of other offering costs.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP stablishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Cash Held in Trust Account

At September 30, 2021, the Company had $58,075,877 in cash held in the Trust Account consisting of cash held in a money market fund

Due to Related Party

The balance of $301,930 is represented by $7,333 accrued for the administrative support services provided by the Sponsor commencing on the date the securities of the Company are first listed on the Nasdaq Capital Market, and $294,597 of accrued expenses paid by the Sponsor on behalf of the Company.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2021, 5,750,000 shares of Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

Net Income (loss) Per Ordinary Share

The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of ordinary shares:

	For the Three Months Ended September 30,						For the Period from February 23, 2021
	2021						(Inception) to September 30, 2021
			non-						non-
	redeemable		redeemable				redeemable		redeemable
	Class A		Class A		Class B		Class A		Class A		Class B
NUMERATOR
Allocation of net loss	$	(219,219)	$	(13,344)	$	(54,805)	$	(253,080)	$	(15,405)	$	(122,477)
DENOMINATOR
Weighted average shares outstanding		5,750,000		350,000		1,437,500		2,848,864		173,409		1,378,693
Basic and diluted net loss per share	$	(0.04)	$	(0.04)	$	(0.04)	$	(0.09)	$	(0.09)	$	(0.09)

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the British Virgin Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

The Company is considered to be a British Virgin Islands business company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands or the United States. As such, the Company’s tax provision was zero for the period presented.

Concentration of credit risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative

scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

XML

Initial Public Offering

7 Months Ended

Sep. 30, 2021

Initial Public Offering

Initial Public Offering

Note 4 — Initial Public Offering

On June 14, 2021, Company consummated its IPO and sold 5,750,000 Units, including 750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment. Each Unit consists of one ordinary share (“Ordinary Share”) and one right (“Right”) to receive one-tenth of one Ordinary Share upon the consummation of an initial business combination. The Units were sold at a price of $10.10 per unit, generating gross proceeds to the Company of $58,075,000.

All of the 5,750,000 Class A ordinary share sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s certificate of incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption to be classified outside of permanent equity.

The Class A ordinary share is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company recognizes changes in redemption value immediately as they occur. Immediately upon the closing of the IPO, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable ordinary shares resulted in charges against additional paid-in capital and accumulated deficit.

As of September 30, 2021, the ordinary shares reflected on the balance sheet are reconciled in the following table:

Gross proceeds from IPO	$	58,075,000
Less:
Ordinary shares issuance costs		(4,163,799)
Plus:
Accretion of carrying value to redemption value		4,163,799
Contingently redeemable ordinary shares	$	58,075,000

XML

Private Placement

7 Months Ended

Sep. 30, 2021

Private Placement

Private Placement

Note 5 — Private Placement

Simultaneously with the closing of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of an aggregate 292,500 Units (“Private Placement Units”), which included the additional 22,500 Private Placement Units sold pursuant to the full exercise of the underwriters’ option to cover the over-allotment.

The Private Placement Units and their component securities will not be transferable, assignable or salable until 30 days after the consummation of the initial Business Combination except to permitted transferees, and they will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

XML

Related Party Transactions

7 Months Ended

Sep. 30, 2021

Related Party Transactions

Related Party Transactions

Note 6 — Related Party Transactions

Founder Shares

On February 23, 2021 and March 4, 2021, the Company’s Sponsor paid $25,001, or approximately $0.017 per share, to cover certain of the offering and formation costs in exchange for an aggregate of 1,437,500 Class B ordinary shares (“Founder shares’), with no par value per share, 187,500 of which are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised. On June 14, 2021, the underwriter exercised the over-allotment option in full, hence, the 187,500 Founder Shares that are no longer subject to forfeiture.

The Company’s initial shareholders have agreed not to transfer, assign or sell any of its founder shares until the earlier to occur of: (A) six months after the completion of the initial Business Combination or (B) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after the initial Business Combination that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property (except as described herein under “Principal Shareholders — Transfers of Founder Shares and Private Placement Units”). (the “Lock-up”).

Promissory Note — Related Party

On March 1, 2021, the Company issued the Promissory Note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $200,000. The Promissory Note is non-interest bearing and payable promptly after the date on which the Maker consummates the IPO of its securities. As of September 30, 2021, the Company had borrowed $200,000 under the promissory note.

Working Capital Loans

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes the initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,150,000 of the Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. The units would be identical to the Private Placement Units. As of September 30, 2021, no such Working Capital Loans were outstanding.

XML

Commitments and Contingencies

7 Months Ended

Sep. 30, 2021

Commitments and Contingencies

Commitments and Contingencies

Note 7 — Commitments & Contingencies

Registration Rights

The holders of the founder shares, Private Placement Units, shares being issued to the underwriters of the Proposed Public Offering, and units that may be issued on conversion of Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Proposed Public Offering requiring the Company to register such securities for resale (in the case of the founder shares, only after conversion to the Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act.

Underwriting Agreement

The underwriters have a 45-day option from June 14, 2021 to purchase up to an additional 750,000 Units, consisting of 750,000 Class A ordinary shares and 750,000 rights to cover over-allotments, if any.

On June 14, 2021, the underwriter fully exercised the over-allotment option to purchase 750,000 Units, and paid an underwriting commission in aggregate of $1,150,000. Additionally, the underwriters will be entitled to a deferred underwriting commissions of 3.5% of the gross proceeds of the IPO held in the Trust Account, or $2,012,500 upon the completion of the Company’s initial Business Combination subject to the terms of the underwriting agreement.

Representative’s Ordinary Shares

The Company issued to Maxim Partners LLC and/or its designees, 57,500 shares upon the consummation of the IPO, the fair value of which is $575. Maxim has agreed not to transfer, assign or sell any such shares until the completion of our initial business combination. In addition, Maxim has agreed (i) to waive its redemption rights with respect to such shares in connection with the completion of our initial business combination and (ii) to waive its rights to liquidating distributions from the trust account with respect to such shares if the Company fails to complete our initial business combination within 12 months from the closing of the IPO, or up to 18 months from the closing of the IPO if the Company extends the period of time to consummate a business combination.

The shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales in this offering pursuant to FINRA Rule 5110(e)(1). Pursuant to FINRA Rule 5110(e)(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the registration statement of which the prospectus forms a part, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following the effective date of the registration statement of which the prospectus forms a part except to any underwriter and selected dealer participating in the offering and their officers, partners, registered persons or affiliates.

Right of First Refusal

For a period beginning on the closing of the IPO and ending 12 months from the closing of a business combination, the Company has granted Maxim a right of first refusal to act as lead-left book running manager and lead left placement agent for any and all future private or public equity, equity-linked, convertible and debt offerings during such period. In accordance with FINRA Rule 5110(g)(6)(A), such right of first refusal shall not have a duration of more than three years from the commencement of sales in the IPO.

XML

Shareholders Equity

7 Months Ended

Sep. 30, 2021

Shareholder's Equity

Shareholder's Equity

Note 8 — Shareholders’ Equity

Preference Shares — The Company is authorized to issue a total of 1,000,000 preferred shares with no par value. As of September 30, 2021, there were no preference shares issued or outstanding.

Class A Ordinary Shares — The Company is authorized to issue a total of 100,000,000 Class A ordinary shares with no par value. As of September 30, 2021, there were 350,000 Class A ordinary shares outstanding, excluding 5,750,000 Class A ordinary shares subject to possible redemption.

Class B Ordinary Shares—The Company is authorized to issue a total of 10,000,000 Class B ordinary shares with no par value. As of September 30, 2021, there were 1,437,500 Class B ordinary shares issued and outstanding.

XML

Subsequent Events

7 Months Ended

Sep. 30, 2021

Subsequent Events

Subsequent Events

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

XML

Summary of Significant Accounting Policies (Policies)

7 Months Ended

Sep. 30, 2021

Summary of Significant Accounting Policies

Basis of Presentation

Basis of Presentation

The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).

Emerging Growth Company Status

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021.

Offering Costs Associated with IPO

Offering Costs Associated with IPO

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO and were charged to shareholders’ equity upon the completion of the IPO. Accordingly, as of September 30, 2021, offering costs in the aggregate of $4,163,799 have been charged to shareholders’ equity (consisting of $1,150,000 of underwriting discount, $2,012,500 of deferred underwriting discount, the fair value of the representative shares of $478,857 and $522,442 of other offering costs.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.

Fair Value Measurements

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP stablishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Cash Held in Trust Account

Cash Held in Trust Account

At September 30, 2021, the Company had $58,075,877 in cash held in the Trust Account consisting of cash held in a money market fund

Due to Related Party

Due to Related Party

The balance of $301,930 is represented by $7,333 accrued for the administrative support services provided by the Sponsor commencing on the date the securities of the Company are first listed on the Nasdaq Capital Market, and $294,597 of accrued expenses paid by the Sponsor on behalf of the Company.

Class A Common Stock Subject to Possible Redemption

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2021, 5,750,000 shares of Class A ordinary shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

Net Income (loss) Per Ordinary Share

Net Income (loss) Per Ordinary Share

The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of ordinary shares:

	For the Three Months Ended September 30,						For the Period from February 23, 2021
	2021						(Inception) to September 30, 2021
			non-						non-
	redeemable		redeemable				redeemable		redeemable
	Class A		Class A		Class B		Class A		Class A		Class B
NUMERATOR
Allocation of net loss	$	(219,219)	$	(13,344)	$	(54,805)	$	(253,080)	$	(15,405)	$	(122,477)
DENOMINATOR
Weighted average shares outstanding		5,750,000		350,000		1,437,500		2,848,864		173,409		1,378,693
Basic and diluted net loss per share	$	(0.04)	$	(0.04)	$	(0.04)	$	(0.09)	$	(0.09)	$	(0.09)

Income Taxes

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the British Virgin Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

The Company is considered to be a British Virgin Islands business company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the British Virgin Islands or the United States. As such, the Company’s tax provision was zero for the period presented.

Concentration of Credit Risk

Concentration of credit risk

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative

scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows.

Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

XML

Restatement of Previously Issued Financial Statements (Tables)

7 Months Ended

Sep. 30, 2021

Restatement of Previously Issued Financial Statements

Summary of impact of the revision on the financial statements

	As Reported		Adjustments		As Restated
Balance Sheet as of June 14, 2021 (per Form 8-K filed on June 21, 2021)
Ordinary shares subject to possible redemption ($)	$	51,793,274	$	6,281,726	$	58,075,000
Ordinary shares Class A, no par value		97		(62)		35
Ordinary shares Class B, no par value		144		—		144
Additional Paid-in Capital		5,016,544		(5,016,544)		—
Accumulated Deficit		(16,776)		(1,265,120)		(1,281,896)
Total Shareholders' Equity (Deficit)	$	5,000,009	$	(6,281,726)	$	(1,281,717)
Number of shares subject to redemption		5,128,047		621,953		5,750,000
Balance Sheet as of June 30, 2021 (per Form 10-Q filed on August 18, 2021)
Ordinary shares subject to possible redemption ($)	$	51,661,459	$	6,413,541	$	58,075,000
Ordinary shares Class A, no par value		98		(63)		35
Ordinary shares Class B, no par value		144		—		144
Additional Paid-in Capital		5,103,358		(5,103,358)		—
Accumulated Deficit		(103,595)		(1,310,120)		(1,413,715)
Total Shareholders' Equity (Deficit)	$	5,000,005	$	(6,413,541)	$	(1,413,536)
Number of shares subject to redemption		5,114,996		635,004		5,750,000

Unaudited Statements of Operations
For the three ended June 30, 2021 and For the period from
February 23, 2021 (Inception) to June 30, 2021 as adjusted for
Temporary Equity related to Public Shares	As Reported		Adjustments		As Restated
Three months ended June 30, 2021
Basic and diluted weighted average shares outstanding, ordinary shares subject to redemption		957,843		116,333		1,074,176
Basic and diluted weighted average shares outstanding, ordinary shares not subject to redemption		1,619,217		(181,717)		1,437,500
Basic and diluted net loss per share per ordinary share subject to possible redemption	$	0.00	$	(0.04)	$	(0.04)
Basic and diluted net loss per share per nonredeemable ordinary share	$	(0.06)	$	0.02	$	(0.04)
For the period from February 23, 2021 (Inception) to June 30, 2021
Basic and diluted weighted average shares outstanding ordinary shares subject to redemption		5,127,279		(4,363,607)		763,672
Basic and diluted weighted average shares outstanding ordinary shares not subject to redemption		1,566,689		(230,263)		1,336,426
Basic and diluted net loss per share per ordinary share subject to possible redemption	$	0.00	$	(0.05)	$	(0.05)
Basic and diluted net loss per share per nonredeemable ordinary share	$	(0.07)	$	0.02	$	(0.05)

Unaudited Statements of Cash Flows
For the six months ended June 30, 2021
as adjusted for Temporary Equity related to Public Shares	As Reported		Adjustments		As Restated
Initial value of shares subject to possible redemption	$	51,661,459	$	6,413,541	$	58,075,000

XML

Summary of Significant Accounting Policies (Tables)

7 Months Ended

Sep. 30, 2021

Summary of Significant Accounting Policies

Schedule of reconciliation of basic and diluted net loss per share

	For the Three Months Ended September 30,						For the Period from February 23, 2021
	2021						(Inception) to September 30, 2021
			non-						non-
	redeemable		redeemable				redeemable		redeemable
	Class A		Class A		Class B		Class A		Class A		Class B
NUMERATOR
Allocation of net loss	$	(219,219)	$	(13,344)	$	(54,805)	$	(253,080)	$	(15,405)	$	(122,477)
DENOMINATOR
Weighted average shares outstanding		5,750,000		350,000		1,437,500		2,848,864		173,409		1,378,693
Basic and diluted net loss per share	$	(0.04)	$	(0.04)	$	(0.04)	$	(0.09)	$	(0.09)	$	(0.09)

XML

Initial Public Offering (Tables)

7 Months Ended

Sep. 30, 2021

Initial Public Offering

Schedule of reconciliation of Balance sheet

As of September 30, 2021, the ordinary shares reflected on the balance sheet are reconciled in the following table:

Gross proceeds from IPO	$	58,075,000
Less:
Ordinary shares issuance costs		(4,163,799)
Plus:
Accretion of carrying value to redemption value		4,163,799
Contingently redeemable ordinary shares	$	58,075,000

XML

Organization and Business Operation (Details)		3 Months Ended	7 Months Ended
	Jun. 14, 2021 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) item $ / shares shares	Jun. 30, 2021 shares
Subsidiary, Sale of Stock [Line Items]
Condition for future business combination, minimum number of businesses | item			1
Obligation to redeem Public Shares if entity does not complete a business combination (as a percent)			100.00%
Redemption of shares calculated based on business days prior to consummation of business combination (in days)			2 days
Investment of cash in Trust Account, per unit | $ / shares		$ 10.10	$ 10.10
Increase in investment of cash in trust account, per unit | $ / shares		$ 0.20	$ 0.20
Condition for future business combination threshold net tangible assets		$ 5,000,001	$ 5,000,001
Threshold period to complete business combination			12 months
Threshold period To complete business combination, if elected to extend business consumption period			18 months
Threshold business days for redemption of public shares			10 days
Maximum allowed dissolution expenses			$ 50,000
Cash equivalents		732,901	732,901
Underwriting discount		1,150,000
Fair value of the representative shares		478,857	478,857
Other offering costs		522,442
Working capital deficit			310,720
Aggregate purchase price			25,001
Proceeds from issuance initial public offering			50,000,006
Payments for investment of cash in Trust Account			(58,075,000)
Proceeds from sale of warrants | shares	292,500			0.10
Deferred underwriters discount	$ 2,012,500	2,012,500	2,012,500
Cash held in Trust Account		$ 58,075,877	$ 58,075,877
Initial Public Offering.
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of units	$ 58,075,000
Purchase price, per unit | $ / shares	$ 10.10
Number of shares in a unit | shares	1
Number of rights in a unit | shares	1
Number of shares in a right | shares	0.1
Investment of cash in Trust Account, per unit | $ / shares		$ 10.10	$ 10.10
Number of units issued | shares	5,750,000
Gross proceeds from units issued	$ 58,075,000
Underwriting discount			$ 1,150,000
Fair value of the representative shares		$ 478,857	478,857
Other offering costs			522,442
Unit price | $ / shares	$ 10.10
Deferred underwriters discount		2,012,500	2,012,500
Transaction costs			4,163,799
Cash held in Trust Account		$ 58,075,000	58,075,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares	292,500
Proceeds from sale of Private Placement Warrants			$ 2,925,000
Exercise price of warrants | $ / shares		$ 10.00	$ 10.00
Proceeds from sale of warrants | shares		292,500	292,500
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares	750,000		750,000
Sponsor
Subsidiary, Sale of Stock [Line Items]
Aggregate purchase price			$ 25,001
Proceeds from unsecured promissory note			$ 200,000

XML

Restatement of Previously Issued Financial Statements (Details) - USD ($)	3 Months Ended		4 Months Ended	7 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Jun. 30, 2021	Sep. 30, 2021	Jun. 14, 2021	Mar. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Redemption value per ordinary share	$ 10.10			$ 10.10
Minimum net tangible assets	$ 5,000,001			$ 5,000,001
Balance Sheet
Additional Paid in Capital	0			0
Accumulated Deficit	(1,701,082)	$ (1,413,715)	$ (1,413,715)	(1,701,082)	$ (1,281,896)
Total shareholders' equity (deficit)	(1,700,903)	$ (1,413,536)	$ (1,413,536)	(1,700,903)	$ (1,281,717)	$ 16,991
Number of shares subject to redemption		5,750,000	5,750,000		5,750,000
Unaudited Statements of Cash Flows as adjusted for Temporary Equity related to Public Shares
Initial value of shares subject to possible redemption			$ 58,075,000	58,075,000
Class A Ordinary Shares
Balance Sheet
Temporary Equity, Carrying Amount, Attributable to Parent	$ 58,075,000			$ 58,075,000
Number of shares subject to redemption	5,750,000			5,750,000
Common shares, par value (in dollars per share)	$ 0	$ 0	$ 0	$ 0	$ 0
Class A ordinary shares subject to possible redemption
Balance Sheet
Temporary Equity, Carrying Amount, Attributable to Parent	$ 58,075,000	$ 58,075,000	$ 58,075,000	$ 58,075,000	$ 58,075,000
Ordinary shares		$ 35	$ 35		35
Number of shares subject to redemption	5,750,000			5,750,000
Unaudited Statements of Operations as adjusted for Temporary Equity related to Public Shares
Weighted average shares outstanding, basic	5,750,000	1,074,176	763,672	2,848,864
Diluted weighted average shares outstanding		1,074,176	763,672
Earning per share	$ (0.04)	$ (0.04)	$ (0.05)	$ (0.09)
Diluted net loss per share per ordinary share	$ 0.00	$ (0.04)	$ (0.05)	$ 0.00
Class A ordinary shares not subject to possible redemption
Balance Sheet
Ordinary shares	$ 35			$ 35
Unaudited Statements of Operations as adjusted for Temporary Equity related to Public Shares
Weighted average shares outstanding, basic	350,000	1,437,500	1,336,426	173,409
Diluted weighted average shares outstanding		1,437,500	1,336,426
Earning per share	$ (0.04)	$ (0.04)		$ (0.09)
Diluted net loss per share per ordinary share		$ (0.04)	$ (0.05)
Class B Ordinary Shares
Balance Sheet
Ordinary shares	$ 144	$ 144	$ 144	$ 144	$ 144
Common shares, par value (in dollars per share)	$ 0	$ 0	$ 0	$ 0	$ 0
Unaudited Statements of Operations as adjusted for Temporary Equity related to Public Shares
Weighted average shares outstanding, basic	1,437,500			1,378,693
Earning per share	$ (0.04)			$ (0.09)
Ordinary shares not subject to redemption
Unaudited Statements of Operations as adjusted for Temporary Equity related to Public Shares
Weighted average shares outstanding, basic	1,787,500			1,552,102
Earning per share	$ (0.04)			$ (0.09)
Diluted net loss per share per ordinary share	$ (0.04)			$ (0.09)
As Reported
Balance Sheet
Additional Paid in Capital		$ 5,103,358	$ 5,103,358		$ 5,016,544
Accumulated Deficit		(103,595)	(103,595)		(16,776)
Total shareholders' equity (deficit)		$ 5,000,005	$ 5,000,005		$ 5,000,009
Number of shares subject to redemption		5,114,996	5,114,996		5,128,047
Unaudited Statements of Cash Flows as adjusted for Temporary Equity related to Public Shares
Initial value of shares subject to possible redemption			$ 51,661,459
As Reported | Class A ordinary shares subject to possible redemption
Balance Sheet
Temporary Equity, Carrying Amount, Attributable to Parent		$ 51,661,459	51,661,459		$ 51,793,274
Ordinary shares		$ 98	$ 98		97
Unaudited Statements of Operations as adjusted for Temporary Equity related to Public Shares
Weighted average shares outstanding, basic		957,843	5,127,279
Diluted weighted average shares outstanding		957,843	5,127,279
Earning per share		$ 0.00	$ 0.00
Diluted net loss per share per ordinary share		$ 0.00	$ 0.00
As Reported | Class A ordinary shares not subject to possible redemption
Unaudited Statements of Operations as adjusted for Temporary Equity related to Public Shares
Weighted average shares outstanding, basic		1,619,217	1,566,689
Diluted weighted average shares outstanding		1,619,217	1,566,689
Earning per share		$ (0.06)
Diluted net loss per share per ordinary share		$ (0.06)	$ (0.07)
As Reported | Class B Ordinary Shares
Balance Sheet
Ordinary shares		$ 144	$ 144		144
Adjustment
Balance Sheet
Additional Paid in Capital		(5,103,358)	(5,103,358)		(5,016,544)
Accumulated Deficit		(1,310,120)	(1,310,120)		(1,265,120)
Total shareholders' equity (deficit)		$ (6,413,541)	$ (6,413,541)		$ (6,281,726)
Number of shares subject to redemption		635,004	635,004		621,953
Unaudited Statements of Cash Flows as adjusted for Temporary Equity related to Public Shares
Initial value of shares subject to possible redemption			$ 6,413,541
Adjustment | Class A ordinary shares subject to possible redemption
Balance Sheet
Temporary Equity, Carrying Amount, Attributable to Parent		$ 6,413,541	6,413,541		$ 6,281,726
Ordinary shares		$ (63)	$ (63)		$ (62)
Unaudited Statements of Operations as adjusted for Temporary Equity related to Public Shares
Weighted average shares outstanding, basic		116,333	(4,363,607)
Diluted weighted average shares outstanding		116,333	(4,363,607)
Earning per share		$ (0.04)	$ (0.05)
Diluted net loss per share per ordinary share		$ (0.04)	$ (0.05)
Adjustment | Class A ordinary shares not subject to possible redemption
Unaudited Statements of Operations as adjusted for Temporary Equity related to Public Shares
Weighted average shares outstanding, basic		(181,717)	(230,263)
Diluted weighted average shares outstanding		(181,717)	(230,263)
Earning per share		$ 0.02
Diluted net loss per share per ordinary share		$ 0.02	$ 0.02

XML

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	7 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Jun. 30, 2021	Jun. 14, 2021	Mar. 04, 2021	Feb. 23, 2021
Unrecognized tax benefits	$ 0	$ 0
Unrecognized tax benefits accrued for interest and penalties	0	0
Deferred underwriters discount	2,012,500	2,012,500		$ 2,012,500
Class A common stock subject to possible redemption, outstanding (in shares)			5,750,000	5,750,000
Proceeds from issuance of private placement		2,925,000
Offering costs	4,163,799
Cash held in Trust Account	58,075,877	58,075,877
Due to related party	301,930	301,930
Underwriting discount	1,150,000
Other offering costs	522,442
Deferred underwriting discount	2,012,500	2,012,500
Federal depository insurance coverage amount	250,000	250,000
Fair value of the representative shares	478,857	478,857
Sponsor
Accrued expense	$ 7,333	7,333
Accrued expense paid		$ 294,597
Class A Ordinary Shares
Class A common stock subject to possible redemption, outstanding (in shares)	5,750,000	5,750,000
Class B Ordinary Shares | Sponsor
Shares subject to forfeiture				187,500	187,500	187,500

XML

Summary of Significant Accounting Policies - Net Income (loss) Per Ordinary Share (Details) - USD ($)	3 Months Ended		4 Months Ended	7 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Jun. 30, 2021	Sep. 30, 2021
Class A ordinary shares subject to possible redemption
NUMERATOR
Allocation of net loss	$ (219,219)			$ (253,080)
DENOMINATOR
Weighted average shares outstanding, basic	5,750,000	1,074,176	763,672	2,848,864
Weighted average shares outstanding, diluted	5,750,000			2,848,864
Basic net loss per common share	$ (0.04)	$ (0.04)	$ (0.05)	$ (0.09)
Diluted net loss per common share	$ 0.00	$ (0.04)	$ (0.05)	$ 0.00
Class A ordinary shares not subject to possible redemption
NUMERATOR
Allocation of net loss	$ (13,344)			$ (15,405)
DENOMINATOR
Weighted average shares outstanding, basic	350,000	1,437,500	1,336,426	173,409
Weighted average shares outstanding, diluted	350,000			173,409
Basic net loss per common share	$ (0.04)	$ (0.04)		$ (0.09)
Diluted net loss per common share		$ (0.04)	$ (0.05)
Class B Ordinary Shares
NUMERATOR
Allocation of net loss	$ (54,805)			$ (122,477)
DENOMINATOR
Weighted average shares outstanding, basic	1,437,500			1,378,693
Weighted average shares outstanding, diluted	1,437,500			1,378,693
Basic net loss per common share	$ (0.04)			$ (0.09)

XML

Initial Public Offering (Details) - USD ($)		7 Months Ended
	Jun. 14, 2021	Sep. 30, 2021
Initial Public Offering.
Subsidiary, Sale of Stock [Line Items]
Number of units issued	5,750,000
Number of shares in a unit	1
Number of rights in a unit	1
Number of shares in a right	0.1
Purchase price, per unit	$ 10.10
Gross proceeds from units issued	$ 58,075,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued	750,000	750,000

XML

Initial Public Offering - Reflected on the balance sheet are reconciled (Details) - USD ($)	3 Months Ended	7 Months Ended
	Jun. 30, 2021	Sep. 30, 2021	Jun. 14, 2021
Subsidiary, Sale of Stock [Line Items]
Number of shares subject to redemption	5,750,000		5,750,000
Accretion of carrying value to redemption value	$ (4,163,799)
Class A ordinary shares subject to possible redemption
Subsidiary, Sale of Stock [Line Items]
Number of shares subject to redemption		5,750,000
Gross proceeds from IPO		$ 58,075,000
Ordinary shares issuance costs		(4,163,799)
Accretion of carrying value to redemption value		4,163,799
Contingently redeemable ordinary shares	$ 58,075,000	$ 58,075,000	$ 58,075,000

XML

Private Placement (Details) - USD ($)		7 Months Ended
	Jun. 14, 2021	Sep. 30, 2021	Jun. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of warrants	292,500		0.10
Private Placement.
Subsidiary, Sale of Stock [Line Items]
Number of units issued	292,500
Threshold period for not to transfer, assign or sell any of their shares or units after the completion of the initial business combination		30 days
Aggregate purchase price		$ 2,925,000
Proceeds from sale of warrants		292,500
Private Placement, Over-Allotment Option
Subsidiary, Sale of Stock [Line Items]
Number of units issued	22,500

XML

Related Party Transactions - Founder Shares (Details) - USD ($)				7 Months Ended
	Jun. 14, 2021	Mar. 04, 2021	Feb. 23, 2021	Sep. 30, 2021	Jun. 30, 2021
Related Party Transaction [Line Items]
Aggregate purchase price				$ 25,001
Initial Public Offering.
Related Party Transaction [Line Items]
Purchase price, per unit	$ 10.10
Number of units issued	5,750,000
Over-allotment option
Related Party Transaction [Line Items]
Number of units issued	750,000			750,000
Class B Ordinary Shares
Related Party Transaction [Line Items]
Common shares, par value	$ 0			$ 0	$ 0
Sponsor
Related Party Transaction [Line Items]
Aggregate purchase price				$ 25,001
Restrictions on transfer period of time after business combination completion				6 months
Sponsor | Class B Ordinary Shares
Related Party Transaction [Line Items]
Aggregate purchase price		$ 25,001	$ 25,001
Purchase price, per unit		$ 0.017	$ 0.017
Number of shares issued		1,437,500	1,437,500
Common shares, par value		$ 0
Shares subject to forfeiture	187,500	187,500	187,500

XML

Related Party Transactions - Additional Information (Details) - USD ($)	Sep. 30, 2021	Mar. 01, 2021
Working capital loans warrant
Related Party Transaction [Line Items]
Outstanding balance of related party note	$ 0
Promissory Note with Related Party
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note		$ 200,000
Outstanding balance of related party note	200,000
Related Party Loans
Related Party Transaction [Line Items]
Loan conversion agreement warrant	$ 1,150,000
Related Party Loans | Working capital loans warrant
Related Party Transaction [Line Items]
Price of warrant	$ 10.00

XML

Commitments and Contingencies (Details)		7 Months Ended	9 Months Ended
	Jun. 14, 2021 USD ($) shares	Sep. 30, 2021 USD ($) item shares	Sep. 30, 2021 USD ($) item shares
Loss Contingencies [Line Items]
Maximum number of demands for registration of securities | item		3	3
Aggregate underwriter cash discount, including over-allotment | $	$ 1,150,000
Deferred underwriting discount, percent		3.50%	3.50%
Deferred underwriters discount | $	$ 2,012,500	$ 2,012,500	$ 2,012,500
Threshold period to complete business combination		12 months
Threshold period To complete business combination, if elected to extend business consumption period		18 months
Over-allotment option
Loss Contingencies [Line Items]
Underwriters option to purchase, term		45 days
Number of units issued	750,000	750,000
Total shares issuable for units		750,000	750,000
Total rights issuable for units		750,000	750,000
Maxim Partners LLC and/or its designees
Loss Contingencies [Line Items]
Amount of fair value agreed to purchase, including over-allotment | $			$ 575
Number of shares agreed to purchase, including over-allotment		57,500	57,500
Threshold period of right of first refusal from business combination closure		12 months

XML

Shareholders Equity - Preferred Stock Shares (Details)	Sep. 30, 2021 $ / shares shares
Shareholder's Equity
Preferred shares, shares authorized	1,000,000
Preferred stock, par value, (per share) | $ / shares	$ 0
Preferred shares, shares issued	0
Preferred shares, shares outstanding	0

XML

Shareholders Equity - Common Stock Shares (Details) - $ / shares	Sep. 30, 2021	Jun. 30, 2021	Jun. 14, 2021	Mar. 31, 2021	Mar. 04, 2021
Class of Stock [Line Items]
Class A common stock subject to possible redemption, outstanding (in shares)		5,750,000	5,750,000
Class A Ordinary Shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	100,000,000
Common shares, par value (in dollars per share)	$ 0	$ 0	$ 0
Common shares, shares issued (in shares)	350,000
Common Stock, Shares, Outstanding	350,000
Class A common stock subject to possible redemption, outstanding (in shares)	5,750,000
Class A ordinary shares subject to possible redemption
Class of Stock [Line Items]
Class A common stock subject to possible redemption, outstanding (in shares)	5,750,000
Class A ordinary shares not subject to possible redemption
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	100,000,000
Common Stock, Shares, Outstanding	350,000
Class B Ordinary Shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	10,000,000
Common shares, par value (in dollars per share)	$ 0	$ 0	$ 0
Common shares, shares issued (in shares)	1,437,500			1,437,500
Common Stock, Shares, Outstanding	1,437,500
Class B Ordinary Shares | Sponsor
Class of Stock [Line Items]
Common shares, par value (in dollars per share)					$ 0
Common shares, shares issued (in shares)	1,437,500
Common Stock, Shares, Outstanding	1,437,500